The delicate fallopian tube is the anatomic pathway to human reproduction. Simple, relatively inexpensive tools and techniques allow radiologists access to the tube for promoting and preventing pregnancy. Description of…
Uterine leiomyomas are the most common female pelvic neoplasm. Commonly referred to as “fibroids,” they consist of smooth muscle tissue and a fibrous extracellular matrix. They can be solitary but…
Uterine leiomyomas or fibroids are the most common uterine and gynecologic neoplasm, with a reported incidence ranging from 20% to 40%. Fibroids are benign tumors that arise from the smooth…
Ovarian neoplasms are histologically diverse, with approximately 15 types among malignant tumors alone. Benign ovarian masses include benign neoplasms and other predominantly cystic or hemorrhagic lesions most commonly arising from…
Vaginal Carcinoma Epidemiology Vaginal carcinoma is predominantly a disease of the postmenopausal woman, with most cases occurring after 60 years of age. It is an uncommon cancer, accounting for 1%…
Fluid collections, lymphadenopathy, and cystic and solid masses are encountered routinely in the practice of gynecology and gynecologic oncology. For example, tuboovarian abscesses (TOAs) may be sequelae of pelvic inflammatory…
Carcinoma of the uterine cervix is the third most common gynecologic malignancy in the United States. According to the cancer facts and figures from the American Cancer Registry (ACR; Atlanta,…
Ectopic pregnancy refers to any pregnancy that occurs outside of the uterine cavity. It is reported to occur in approximately 2% of all pregnancies in the United States. Its incidence…
Imaging of Benign Ovarian Lesions Sonography, especially transvaginal ultrasound (TVUS), has become the primary imaging technique for the evaluation of the ovary. Because the majority of ovarian lesions are benign,…
Uterine carcinomas can be divided primarily into endometrial cancer and uterine sarcomas. Cervical cancer is also considered a uterine malignancy but is covered in Chapter 33 . Endometrial cancer, primarily…
